7-150951689-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.1704G>A(p.Trp568*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000238.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- long QT syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- long QT syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- short QT syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- short QT syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: MODERATE, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KCNH2 | NM_000238.4 | c.1704G>A | p.Trp568* | stop_gained | Exon 7 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KCNH2 | ENST00000262186.10 | c.1704G>A | p.Trp568* | stop_gained | Exon 7 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461826Hom.: 0 Cov.: 34 AF XY: 0.00000275 AC XY: 2AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
p.Trp568Stop (TGG>TGA):c.1704 G>A in exon 7 of the KCNH2 (aka HERG) gene (NM_000238.2)The Trp568Stop mutation in the KCNH2 gene has been reported in association with LQTS (Kapplinger J et al., 2009). This mutation was reported in one patient with LQTS and it was absent from 2,600 control alleles. The Trp568Stop mutation is predicted to cause loss of normal protein function either due to a prematurely truncated protein or absent protein product due to nonsense mediated mRNA decay. Other nonsense mutations in the KCNH2 gene have also been reported in association with LQTS.In summary, Trp568Stop mutation in the KCNH2 gene is interpreted as a disease-causing mutation. The variant is found in LQT panel(s). -
Cardiovascular phenotype Pathogenic:1
The p.W568* pathogenic mutation (also known as c.1704G>A), located in coding exon 7 of the KCNH2 gene, results from a G to A substitution at nucleotide position 1704. This changes the amino acid from a tryptophan to a stop codon within coding exon 7. In a study of long QT syndrome clinical genetic testing, this alteration was reported in one patient; however, clinical details were limited (Kapplinger JD et al. Heart Rhythm. 2009;6:1297-303). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at